Osteopathic Manipulative Treatment (OMT) for Covid19

Phase-Based Progress Estimates

Effectiveness

Safety

Covid19+6 More

Osteopathic Manipulative Treatment (OMT) - Other

You have a chance of qualifying for this trial. We made sure your application will take less than 5 minutes.

Eligibility

18+

All Sexes

What conditions do you have?

Select

Eligibility

18+

All Sexes

What conditions do you have?

Select

Study Summary

This trial will test if adding osteopathic manipulative treatment to current mRNA COVID-19 vaccines can enhance the immune response.

Eligible Conditions

Covid19

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Covid19

VBI-2901a

SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03, Dosage B

VBI-2902a

Study Objectives

3 Primary · 2 Secondary · Reporting Duration: Through study completion, an average of 1 year

Year 1

IgG antibody titer levels Percentage Change

IgM antibody titer levels Percentage Change.

Year 1

IgM and IgG antibody titer duration

Year 1

Adverse Effects/Side Effects

Medication Usage

Trial Safety

Safety Progress

1 of 3

Other trials for Covid19

VBI-2901a

SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03, Dosage B

VBI-2902a

Trial Design

2 Treatment Groups

Control

1 of 2

OMT Intervention Arm

1 of 2

Active Control

Experimental Treatment

200 Total Participants · 2 Treatment Groups

Primary Treatment: Osteopathic Manipulative Treatment (OMT) · No Placebo Group · N/A

OMT Intervention Arm

Other

Experimental Group · 1 Intervention: Osteopathic Manipulative Treatment (OMT) · Intervention Types: Other

ControlNoIntervention Group · 1 Intervention: Control · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline

Screening: ~3 weeks

Treatment: Varies

Reporting: through study completion, an average of 1 year

Who is running the clinical trial?

American College of Osteopathic PhysiciansUNKNOWN

Xavier-Nichols FoundationUNKNOWN

Western University of Health SciencesLead Sponsor

19 Previous Clinical Trials

1,057 Total Patients Enrolled

American Osteopathic FoundationUNKNOWN

1 Previous Clinical Trials

20 Total Patients Enrolled

Osteopathic Physicians and Surgeons of CaliforniaUNKNOWN

Jesus Sanchez, DO4.04 ReviewsPrincipal Investigator - Professor of Family Medicine

Western University of Health Sciences

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

I will be receiving the mRNA COVID-19 vaccine at Western University of Health Sciences.

Are 18 to 65 years old.

I have not previously received a COVID-19 vaccine.

About The Reviewer

Michael Gill - B. Sc.

First Published: October 20th, 2021

Last Reviewed: October 26th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References